Search Results for "Ranbaxy Launches Atorvastatin In Us"

12:56 EDT 1st July 2015 | BioPortfolio

Matching Channels

None

Matching News

FTC puts conditions on Sun Pharma’s proposed acquisition of Ranbaxy

Indian drugmakers Sun Pharmaceutical Industries Ltd. and Ranbaxy Laboratories have agreed to divest Ranbaxy’s interests in generic minocycline tablets in order to settle US Federal Trade Commission ...

Caution with Lipitor and boceprevir use

The summary of product characteristics for Lipitor (atorvastatin; Pfizer) now advises that patients who are concomitantly taking boceprevir should have a lower starting dose of atorvastatin and should...

With Ranbaxy Under Belt, Sun Eyes Fast Track Global Growth

Sun and Ranbaxy have finally combined into a single global company, but that could be just the beginning of a series of fresh challenges. Sun said it will look at growing its businesses faster than th...

Nexium Generics: Ranbaxy’s Exclusivity Loss Is Teva’s Gain

Teva’s readiness for approval prompts U.S. FDA conclusion that Ranbaxy forfeited its rights to 180-day exclusivity for AstraZeneca’s proton pump inhibitor; Ranbaxy is still making its case in cour...

FTC Clears Sun Pharma's $4B Purchase of Ranbaxy

NEW YORK (AP) — Sun Pharmaceuticals will sell the rights to one generic drug as part of its purchase of competitor Ranbaxy Laboratories, U.S. antitrust regulators said Friday.The Federal Trade Commi...

Sun Pharma finally completes Ranbaxy acquisition

Indian generic drugmaker Sun Pharmaceutical Industries has at last completed the merger of Ranbaxy Laboratories…

Ranbaxy fails to reverse FDA decision over Valcyte and Nexium

Indian generics company Ranbaxy has yet again failed in its bid to become the first company in the US to sell generic versions of the AstraZeneca blockbuster acid-reflux drug Nexium (esomeprazole) and...

Sun Pharma gets US FTC nod to buy Ranbaxy

Biospectrum The early termination of the waiting period under the HSR Act satisfies one of the essential conditions to ...

Matching PubMed Articles

Lipid-lowering efficacy of atorvastatin.

This represents the first update of this review, which was published in 2012. Atorvastatin is one of the most widely prescribed drugs and the most widely prescribed statin in the world. It is therefor...

Paradoxical effects of atorvastatin on renal tubular cells: an experimental investigation.

Atorvastatin has antioxidant activity and has been reported to increase blood antioxidant capacity. This study aimed to evaluate the effect of different doses of atorvastatin on gentamicin-induced kid...

Can atorvastatin calcium cause asymptomatic hypercalcemia?

The use of statins may have unnatural effects. A 54-year-old woman was admitted to the hospital with an incidental finding of hypercalcemia (10.8 mg/dL). There was no disease other than hyperlipidemia...

Impact of low dose atorvastatin on development of new-onset diabetes mellitus in Asian population: Three-year clinical outcomes.

High dose atorvastatin is known to be associated with new onset diabetes mellitus (NODM) in patients with high risk for developing diabetes mellitus (DM). However, low dose atorvastatin is more common...

Physiologically Based Pharmacokinetic Modeling of Disposition and Drug-Drug Interactions for Atorvastatin and its Metabolites.

Atorvastatin is the most commonly used of all statins to lower cholesterol. Atorvastatin is extensively metabolized in both gut and liver to produce several active metabolites. The purpose of the pres...

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement